Home » Topics » Medical technology

Medical technology
RSS

Contracts: Exogen to provide data management for North Shore-Long Island Jewish

Jan. 10, 2008

Agreements roundup: Home Diagnostics to be supplier of glucose monitors to Rite Aid

Jan. 10, 2008

Deals: Abraxas, new OIS subsidiary, acquires assets of AcerMed

Jan. 10, 2008

By Amanda Pedersen

Gene variant seen as offering new clues to the cause of ALS

Jan. 10, 2008

By Sharon Kingman

xTAG (RVP) assay from Luminex promises quick viral detection

Jan. 10, 2008

Industry 'Anemic, Not Awful' as Year Begins: VC Director

Jan. 10, 2008

Bayhill Files for IPO; Seeking $86M for Autoimmune Drugs

Jan. 10, 2008

By Jennifer Boggs

Sepracor Enters $175M Deal with Bial for Epilepsy Drug

Jan. 9, 2008

Faust Signs Research Deal with Takeda for GPCRs

Jan. 9, 2008

By James Etheridge

Gene Variant Could Provide Clues to the Cause of ALS

Jan. 9, 2008

By Sharon Kingman

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...